SCHEMBL25622707

SCHEMBL25622707

CC1CC2(CCCCO2)CCN1C

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.35
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19121424 0.89 OPRM1 (0.32)
SCHEMBL10141366 0.87 KCNH2 (0.33) KCNH2KMT2A
SCHEMBL10141117 0.81 KMT2A (0.32) KMT2A
SCHEMBL2757446 0.81 KMT2A (0.32) KMT2A
SCHEMBL14985374 0.75
SCHEMBL15962736 0.72 KCNH2 (0.44) KCNH2KMT2A
SCHEMBL25617760 0.72
SCHEMBL25622706 0.71 OPRK1 (0.31) KCNH2KMT2A
SCHEMBL12810121 0.70 KCNH2 (0.35) KCNH2
SCHEMBL26049873 0.70 KCNH2 (0.32) KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4194451-A1 COMPLEMENT FACTOR B INHIBITOR, AND PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Meiyue Biotech Development Co., Ltd. (CN) 2023-06-14 EP disclosed